Answer
Faricimab (Vabysmo) should preferably be avoided during pregnancy as a precaution unless the potential benefit outweighs the potential risk to the foetus, because pregnancy data are absent or limited.
Sources for this answer
- Vabysmo 120 mg/mL solution for injectionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked